Name: Boris Guo

Academic qualifications:

2000-2005   B. Med.    Hebei North University,  Hebei, China

2005-2008   M. Med.   Shanghai University of  Chinese Medicine,

                               Shanghai, China; Luo Yang Institute of Orthopedics &  

                               Traumatology; Department of Rehabilitation Sciences,

                               The Hong Kong  Polytechnic University, Hong Kong

2009-2012   Ph.D.       Department of  Orthopaedics& Traumatology,

                               The Chinese University of Hong Kong

Previous academic positions held:

2004-2005   Resident                      The First Affiliated Hospital of Hebei North University

2007-2008   Resident                      Luo Yang Orthopeadic-Traumatology Hospital

2008-2009   Research Assistant        Department of  Rehabilitation Sciences,

                                                  The Hong Kong Polytechnic University, Hong Kong

2009-2012   Ph.D. Student               Department of  Orthopaedics& Traumatology,

                                                  The Chinese University of Hong Kong

Present academic position:

2012-   Post-doctoral Research  Fellow  Institute for Advancing Translational Medicine in

                                                      Bone & Joint Diseases, Hong Kong Baptist Unviersity

Previous relevant research work:

Technical expertise    Pharmacological Study, Pharmaceutical Analysis, Pharmacokinetic,

                             toxicokinetic

Research area          Molecular understandings  and RNAi-based & phytotherapy-based

                             translational research in bone &  Joints diseases.Luo Yang Orthopeadic-

                             Traumatology Hospital

Awards and Recognitions:

GuoBS.Therapeutic RNAitargeting CKIP-1 for promoting bone formation inan aged rat model of postmenopausal osteoporosis.Young Investigator Award.AmericanSociety for Bone and Mineral Research. San Diego 2011.

Published Papers:

 1.  Wang X, Guo B (co-firstauthor)…Zhang G*, Li Y*. miR-214 targets ATF4 toinhibit bone

      formation. Nat Med.2013;19(1):93-100.

 2.  Guo B,Peng S…, Lu A*, ZhangG*. Recent developments in bone anabolic therapy for

      osteoporosis. Expert RevEndocrinolMetab. 2012; 7(6):677-685.

 3.  Zhang G*, Guo BS (co-firstauthor), Wu H, Tang T, Zhang BT, et al. A delivery system

      targeting bone formation surfaces to facilitate RNAi-based anabolic therapy. Nat Med.

      2012;18:307-14.

 4.  Guo BS, Cheung Kwok-Kuen,Yeung SS, Zhang BT, Yeung EW*. Electrical Stimulation

      Influences Satellite Cell Proliferation and Apoptosis in Unloading-Induced Muscle Atrophy

      in  Mice. PLoSOne. 2012; 7(1):e30348.